MSB Trading 2021 - paradigm shift, page-1319

The big difference between Gamestop/AMC and MSB in relation to being a shorter's plaything is that MSB actually has products that are already in development, are already or could soon be licensed for BIG BUCKS, and if a few balls roll our way, could actually be approved for use in megamarkets within the next 6-18 months (where some revenues (which continue to grow) are already rolling in).

Poor Gamestop's day in the sun is likely long past, unless it really comes up with some left-field idea to make itself relevant in a digital world (sorry, Blockbuster!).

Poor AMC is a COVID long-hauler...no one wants to sit in a cinema next to COVIDiots not wearing masks. Plus, with studios moving quickly to adapt to a cinema-less society, future profits may also be at issue.

You can argue that shorters had the right idea that these were dying companies...just not to the tune of 140% of the float (greedy pr*cks!).

We all know the pattern for MSB and its remora-like shorters. Good news, price goes up...then languishes. Shorters come in to sow doubt, weak hands fold and sell, price drops, shorters clean up...until the next bit of good news..wash, rinse, repeat.

If the Moms and Dads haven't figured out this pattern yet (it's played out about 20 times since I have been an MSB holder...), then I have no pity for them. Do your research, invest in companies YOU (not your mates, not the financial press, not anyone else) believe in, have an investment thesis that accounts and adjusts for BAD NEWS, and have some guts to stick with it through down times.

Shorters are a pest, but they aren't killing MSB, and if it's that easy to scare investors away from their MSB shares, those investors aren't good candidates for MSB shareholding (or Biotech investing) to begin with.